June 5, 2024
Little known fact: Florence Nightingale might have been the most famous clinician to notice and openly comment on the role of hospital design in patient care. […]
June 5, 2024
PARIS — Allergic comorbidities such as asthma and rhinitis are common among pregnant women. During the 19th French-speaking Congress of Allergology, Dario Ebode, MD, otolaryngologist and […]
June 5, 2024
A vacation can be the most beautiful time of the year. Yet many people are afraid of traveling because they cannot tolerate trips by ship, plane, […]
June 5, 2024
NASHVILLE, Tennessee — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers […]
June 5, 2024
Sofia Spieler, a Boston public relations professional who has been losing weight on Wegovy, said her “snack monster” has essentially disappeared after she’s had a lifelong […]
June 4, 2024
The FDA is conducting a Model-Informed Drug Development (MIDD) Paired Meeting Program that will build on the success of the MIDD Paired Meeting Pilot by continuing […]
June 4, 2024
Upadacitinib (Rinvoq) is now indicated for patients aged 2 years or older with active polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic arthritis (PsA) who cannot tolerate […]
June 4, 2024
CDER professionals participate in several meetings, conferences and workshops throughout the year. Appealing primarily to the pharmaceutical industry and health care professionals, topics can range from users […]
June 4, 2024
The Patient-Focused Drug Development Program Staff leads initiatives and provides strategic, regulatory, program, and policy assistance within the Center for Drug Evaluation and Research (CDER) to […]